Literature DB >> 24855198

Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modified.

Ali Javaheri1, Daniel J Rader2.   

Abstract

Entities:  

Keywords:  Editorials; apolipoproteins; cholesterol; coronary artery disease; lipoproteins, HDL

Mesh：

Substances：

Year:  2014        PMID： 24855198      PMCID： PMC4104775          DOI： 10.1161/CIRCRESAHA.114.303974

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  26 in total

Review 1.  Formation of dysfunctional high-density lipoprotein by myeloperoxidase.

Authors:  Stephen J Nicholls; Lemin Zheng; Stanley L Hazen
Journal:  Trends Cardiovasc Med       Date:  2005-08       Impact factor: 6.677

2.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

3.  High-density lipoproteins neutralize C-reactive protein proinflammatory activity.

Authors:  Carol Wadham; Nathaniel Albanese; Jane Roberts; Lijun Wang; Christopher J Bagley; Jennifer R Gamble; Kerry-Anne Rye; Philip J Barter; Mathew A Vadas; Pu Xia
Journal:  Circulation       Date:  2004-04-12       Impact factor: 29.690

4.  Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein.

Authors:  Constanze Bergt; Xiaoyun Fu; Nabiha P Huq; Jeff Kao; Jay W Heinecke
Journal:  J Biol Chem       Date:  2003-12-03       Impact factor: 5.157

5.  Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.

Authors:  Sanjay Patel; Brian G Drew; Shirley Nakhla; Stephen J Duffy; Andrew J Murphy; Phillip J Barter; Kerry-Anne Rye; Jaye Chin-Dusting; Anh Hoang; Dmitri Sviridov; David S Celermajer; Bronwyn A Kingwell
Journal:  J Am Coll Cardiol       Date:  2009-03-17       Impact factor: 24.094

6.  Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function.

Authors:  Dao-Quan Peng; Gregory Brubaker; Zhiping Wu; Lemin Zheng; Belinda Willard; Michael Kinter; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-08-07       Impact factor: 8.311

7.  High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases.

Authors:  Chieko Mineo; Ivan S Yuhanna; Michael J Quon; Philip W Shaul
Journal:  J Biol Chem       Date:  2003-01-02       Impact factor: 5.157

8.  Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I.

Authors:  Baohai Shao; Giorgio Cavigiolio; Nathan Brot; Michael N Oda; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

9.  Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.

Authors:  Baohai Shao; Chongren Tang; Abhishek Sinha; Philip S Mayer; George D Davenport; Nathan Brot; Michael N Oda; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Circ Res       Date:  2014-03-19       Impact factor: 17.367

10.  Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species.

Authors:  Subramaniam Pennathur; Constanze Bergt; Baohai Shao; Jaeman Byun; Sean Y Kassim; Pragya Singh; Pattie S Green; Thomas O McDonald; John Brunzell; Alan Chait; John F Oram; Kevin O'brien; Randolph L Geary; Jay W Heinecke
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157
View more
  5 in total

Review 1.  Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

Review 2.  HDL Composition, Heart Failure, and Its Comorbidities.

Authors:  Ahmed Diab; Carla Valenzuela Ripoll; Zhen Guo; Ali Javaheri
Journal:  Front Cardiovasc Med       Date:  2022-03-08

3.  Concentration of Smaller High-Density Lipoprotein Particle (HDL-P) Is Inversely Correlated With Carotid Intima Media Thickening After Confounder Adjustment: The Multi Ethnic Study of Atherosclerosis (MESA).

Authors:  Daniel Seung Kim; Yatong K Li; Griffith A Bell; Amber A Burt; Tomas Vaisar; Patrick M Hutchins; Clement E Furlong; James D Otvos; Joseph F Polak; Martinson Kweku Arnan; Joel D Kaufman; Robyn L McClelland; W T Longstreth; Gail P Jarvik
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

4.  Altered composition and functional profile of high-density lipoprotein in leprosy patients.

Authors:  Robertha Mariana R Lemes; Carlos Adriano de M E Silva; Maria Ângela de M Marques; Georgia C Atella; José Augusto da C Nery; Maria Renata S Nogueira; Patricia S Rosa; Cléverson T Soares; Prithwiraj De; Delphi Chatterjee; Maria Cristina V Pessolani; Cristiana S de Macedo
Journal:  PLoS Negl Trop Dis       Date:  2020-03-30

5.  Circulating lipid and lipoprotein profiles and their correlation to cardiac function and cardiovascular outcomes in patients with acute myocardial infarction.

Authors:  Haoyu Wu; Chen Wang; Gulinigaer Tuerhongjiang; Xiangrui Qiao; Yiming Hua; Jianqing She; Zuyi Yuan
Journal:  J Investig Med       Date:  2021-05-10       Impact factor: 2.895
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.